Calling A Q-Sub: New Guidance On Seeking Feedback From FDA
Executive Summary
A new US FDA draft guidance on the "Q-Submission Program" (Q-Sub) spotlights certain mechanisms, including pre-submissions, available to sponsors to interact with the agency before or after actually submitting a 510(k), PMA, IDE or other specific submission.
You may also be interested in...
Final Q-Sub Guidance Describes FDA Meeting Policy
A new final guidance document from the US FDA explains how the agency wants device developers to use its Q-Submission Program to get agency feedback outside the formal product submission process.
FDA Eyes Upclassification, Labeling Guidance To Address Stapler Risks
The US agency sent a letter to health-care providers spotlighting its analysis of the increasing numbers of adverse events linked to surgical staplers and implantable staples, and its plans for a draft guidance on labeling and an advisory panel meeting to consider a 510(k) requirement for the products.
Device Week, March 8, 2019 – Scott Gottlieb Resigns
On the latest Medtech Insight podcast, David Filmore and Ferdous Al-Faruque discuss the unexpected news that Scott Gottlieb is leaving US FDA next month. What has been his legacy for medtech, and who will replace him?